Prioritize recurring consumables, AI analytics, FFPE-compatible automation and end-to-end workflows; target oncology, research institutes and CRO partnerships.Dublin, Oct. 08, 2026 (GLOBE NEWSWIRE) -- ...
Panel discussion to explore competitive differentiation as AI reshapes drug discovery and development; TORONTO, Oct. 07, 2026 (GLOBE NEWSWIRE) -- NetraMark Holdings Inc. (the "Com ...
LONDON, ON and HERZLIYA, Israel, Oct. 5, 2026 /PRNewswire/ -- EpiSignInc. and GeneyxGenomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis for ...
EpiSign Inc. and Geneyx Genomex Ltd. today announced a partnership to advance the integration of genomic and epigenomic analysis ...
When researchers measure the activity of thousands of genes at once, they face a paradox that has shaped computational biology for decades: far too many variables and far too few samples. A single DNA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results